Kowin Investments Inc - CA Los Angeles, Montebello 90640

Kowin Investments Inc entered the industry of Commercial Medical Research in 1996 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 5312100, which describes it as a Commercial Medical Research. For further clarification, the SIC classifies this business under the code 8731 and described it as a Commercial Medical Research. The business provides service to the B2B market.

To acquire more information, please contact Pui Yuk, Manager by calling (323) 721-5500 during business hours. You can also write to the business’ Single Location at 830 North Wilcox Avenue, Montebello, California CA 90640. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Kowin Investments Inc
Representative: Pui Yuk, Manager
Place of Business: 830 North Wilcox Avenue, Montebello, CA 90640
Contact Number: (323) 721-5500
Type of Service: Commercial Medical Research
SIC Number: 8731
NAICS Number: 5312100
Locality: Single Location
Market Type: B2B (Business to Business)
Began: 1996
Income/Year: $100.000 to $499.999
Laborers: 1 to 4
Share This Company:

Kowin Investments Inc is a company operating from Los Angeles, California providing professional Commercial Medical Research and relevant B2B variables. It was founded in 1996 and registered with the SIC code 8731 as Commercial Medical Research, and with the NAICS code 5312100 as Commercial Medical Research.

With a current employee count of 1 to 4, Kowin Investments Inc has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Pui Yuk, Manager at (323) 721-5500 for related queries, or to locate its Single Location using the coordinates 34.027407,-118.123971.

The Single Location can also be found at the street address 830 North Wilcox Avenue in Montebello, California 90640 and can be engaged online through the company website at , the company Twitter , and Facebook page .